QIAGEN IPA
Identifying novel drug targets in paraganglioma
68 views
If you'd like to explore a new way to identify potential new drug targets, you won't want to miss this unique opportunity to learn from industry experts about:
How ML used known relationships in the QKG to infer hidden relationships between potential targets and diseases
A library of 1500 disease networks available in QIAGEN Ingenuity Pathway Analysis (IPA)
MicroMatrices' research into paraganglioma and evaluation of novel gene associations predicted by our disease network
Opportunities to verify new drug targets for paraganglioma as well as potential targets in other diseases
Related videos
QIAGEN IPA
Discovery from public data (GEO, SRA and more) using Ingenuity Pathway Analysis
Per user feedback, we are hosting a comprehensive training on how to...
QIAGEN IPA
The epididymis: Balancing the burden and responsibility of fertility
The responsibility of fertility is disproportionately placed on women, who...
QIAGEN IPA
What’s new in QIAGEN IPA Fall Release 2023?
Interested in learning about new features and functionalities that have been...
QIAGEN IPA
Multi-omics (metabolomics, proteomics, transcriptomics) analysis using QIAGEN Ingenuity Pathway...
This 90-minute training session is about how QIAGEN Ingenuity Pathway...